• Explore /
  • Poster
  • / Circulating tumor derived cell-free DNA (ctDNA) to predict recurrence of metastatic colorectal cancer (mCRC) following curative intent surgery or radiation.

Circulating tumor derived cell-free DNA (ctDNA) to predict recurrence of metastatic colorectal cancer (mCRC) following curative intent surgery or radiation.

Abstract Poster

Authors

null

Bryant Chee

University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

Bryant Chee , Faaiz Ibrahim , Mikaela Esquivel , Emily E. Van Seventer , Joy X. Jarnagin , Li Zhang , Jin Hyun Ju , Kristin Sedgwick Price , Victoria M. Raymond , Carlos U. Corvera , Kenzo Hirose , Eric K. Nakakura , Katherine Van Loon , Ryan Bruce Corcoran , Aparna Raj Parikh , Chloe Evelyn Atreya

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 3565)

DOI

10.1200/JCO.2021.39.15_suppl.3565

Abstract #

3565

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Mikaela Esquivel

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Multiomic analysis for minimal residual disease detection: Addressing challenges in stage II-III colon cancer from COSMOS-CRC-01.

Multiomic analysis for minimal residual disease detection: Addressing challenges in stage II-III colon cancer from COSMOS-CRC-01.

First Author: Yoshiaki Nakamura

First Author: Revathi Kollipara

First Author: Yuichiro Tsukada